Evaluation of Glycosylated Hemoglobin (HbA1c) Levels in Hypothyroid and Hyperthyroid Patents

Dr.Pankaj Mohan Shrivastava; Dr.(Prof.) K.K. Singh

Volume : VIII, Issue : III, March - 2019

Evaluation of Glycosylated Hemoglobin (HbA1c) Levels in Hypothyroid and Hyperthyroid Patents

Dr. Pankaj Mohan Shrivastava, Dr. Prof. K. K. Singh

Abstract :

INTRODUCTION: Almost one–third of the world’s population lives in areas of iodine deficiency. Thyroid hormoneaction has long been recognized as an important determinant of glucose homeostasis. Diabetes and thyroid disorders have a propensity to appear together in patients OBJECTIVES: To compare and correlate the glycosylated Hb levels and TSH levels in non diabetic patients. METHODOLOGY: The cross sectional study was conducted among 30 patients of diagnosed thyroid disorders. Thebiochemical parameters were Hemoglobin, TLC, glycemic control (fasting and post prandial blood glucose levels, glycated haemoglobin A1c), blood urea, serum creatinine and a thyroid profile (TSH, T3, and T4). These parameters were measured and compared with the normal population. RESULTS: Out of 30 patients 26 were diagnosed as hypothyroid and 4 were diagnosed as hyperthyroid. HbA1c levelswere found to be elevated in patients of thyroid disorders (hypothyroidism and hypothyroidism) as compared to control. CONCLUSION: Based on this study all the thyroid patients especially hyperthyroid patients should have regularcheckup of their glucose levels. Patients should have adequate treatment of the thyroid disorders and thus should prevent themselves from adverse effects of hyperglycemia